Christopher Browne - Tweedy, Browne Co
Holding/activity history for Vertex Pharmaceuticals (VRTX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 40,387 | 1.43 | Add 3.16% | 0.04 | $446.54 | $18,034,411 | SEC |
| 2025 Q4 | 39,148 | 1.43 | Add 0.21% | <0.01 | $453.36 | $17,748,137 | SEC |
| 2025 Q3 | 39,065 | 1.33 | Add 4.86% | 0.06 | $391.64 | $15,299,417 | SEC |
| 2025 Q2 | 37,253 | 1.54 | Reduce 2.77% | 0.05 | $445.20 | $16,585,036 | SEC |
| 2025 Q1 | 38,316 | 1.65 | Reduce 5.70% | 0.06 | $484.82 | $18,576,363 | SEC |
| 2024 Q4 | 40,631 | 1.10 | Reduce 24.20% | 0.29 | $402.70 | $16,362,104 | SEC |
| 2024 Q3 | 53,600 | 1.19 | Reduce 1.37% | 0.02 | $465.08 | $24,928,288 | SEC |
| 2024 Q2 | 54,346 | 1.17 | Reduce 18.52% | 0.24 | $468.72 | $25,473,057 | SEC |
| 2024 Q1 | 66,699 | 1.31 | Reduce 0.10% | <0.01 | $418.01 | $27,880,849 | SEC |
| 2023 Q4 | 66,764 | 1.33 | Reduce 10.99% | 0.15 | $406.89 | $27,165,604 | SEC |
| 2023 Q3 | 75,004 | 1.40 | Buy | 1.40 | $347.74 | $26,081,891 | SEC |